ArticleBMC bioinformatics2025
scMFF: a machine learning framework with multiple feature fusion strategies for cell type identification.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Accurate cell type classification is critical for downstream analysis in single-cell RNA sequencing (scRNA-seq). Most existing methods rely on a single type of feature representation-such as statistical, information theory, matrix factorization, or deep learning-based features. However, each captures different aspects of the data, and no single feature type can fully represent the complex differences between cell types. Moreover, naïvely concatenating multiple features may introduce redundancy or noise, reducing model performance. To address these challenges, we propose scMFF, which is a multiple feature fusion framework that integrates four features and explores six fusion strategies in combination with various classifiers for single-cell type classification. Comprehensive evaluations on 42 disease-related datasets and an external COVID-19 dataset demonstrate that scMFF outperforms single-feature approaches in terms of performance and stability, providing a reliable and effective solution for scRNA-seq data analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.